Xu Jinyi, Niu Xiaoqiang
Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
J Gastroenterol Hepatol. 2025 May;40(5):1157-1165. doi: 10.1111/jgh.16911. Epub 2025 Feb 25.
The efficacy of primary tumor resection (PTR) for colorectal cancer lung metastases (CRLM) is unclear. This study used the SEER database to investigate if PTR improves prognosis in CRLM patients and developed a nomogram to predict the likelihood of benefiting from PTR.
Patients with CRLM from the SEER database (2010-2019) were included. Propensity score matching (PSM) balanced PTR and non-PTR groups. Kaplan-Meier analysis compared overall and cancer-specific survival. Cox regression identified survival factors. The PTR group was divided into training and validation sets (7:3 ratio) for nomogram development using logistic regression. Nomogram performance was validated using ROC curves, calibration curves, and decision curve analysis.
A total of 3264 CRLM patients were included (2459 with PTR, 805 without). After 1:1 PSM, each group had 484 patients. PTR significantly improved survival (p < 0.001). Logistic regression identified age, race, T-stage, chemotherapy, and metastases to the liver, brain, and bone as risk factors. The nomogram showed excellent predictive performance and clinical utility.
PTR improves survival in CRLM patients, and the nomogram effectively predicts the benefit of PTR.
原发性肿瘤切除(PTR)对结直肠癌肺转移(CRLM)的疗效尚不清楚。本研究使用监测、流行病学和最终结果(SEER)数据库来调查PTR是否能改善CRLM患者的预后,并开发了一种列线图来预测从PTR中获益的可能性。
纳入SEER数据库(2010 - 2019年)中的CRLM患者。倾向评分匹配(PSM)平衡了PTR组和非PTR组。Kaplan - Meier分析比较了总生存期和癌症特异性生存期。Cox回归确定生存因素。使用逻辑回归将PTR组分为训练集和验证集(7:3比例)以开发列线图。使用ROC曲线、校准曲线和决策曲线分析验证列线图的性能。
共纳入3264例CRLM患者(2459例接受PTR,805例未接受)。经过1:1的PSM后,每组有484例患者。PTR显著改善了生存期(p < 0.001)。逻辑回归确定年龄、种族、T分期、化疗以及肝、脑和骨转移为危险因素。该列线图显示出优异的预测性能和临床实用性。
PTR可改善CRLM患者的生存期,且该列线图能有效预测PTR的获益情况。